Pinsent Masons advises UDG Healthcare on circa £84 million acquisition of STEM Marketing

31 Oct 2016 | 04:40 pm | 1 min. read

International law firm Pinsent Masons has advised UDG Healthcare plc, a leading provider of clinical, commercial, communication and packaging services to the healthcare industry, on its acquisition of STEM Marketing Limited for a total consideration of up to £84 million.

The acquisition is in line with UDG’s global growth strategy of expanding its market leading positions providing services to the pharmaceutical sector and significantly expands the service offering and capabilities of its Ashfield Commercial and Medical division and complements UDG’s Ashfield Healthcare Communications division’s global offering.

FTSE 250, Dublin-based UDG has 7,000 employees at operations across 20 countries including the US, UK, Ireland and Germany. STEM Marketing is the leading global provider of commercial, marketing and medical audits to pharmaceutical companies across 35 countries.

The Pinsent Masons team was led by corporate partner Helen Ridge supported by Alasdair Weir and Rob Cunningham, Jon Robinson and Louise Fullwood.

Manchester office head at Pinsent Masons, Helen Ridge, said: “We are delighted to have worked with long standing client UDG Healthcare on yet another acquisition. As this sector of the pharmaceuticals industry continues to develop at rapid pace, companies such as UDG are at the forefront of market leading innovation.”

Robert O’Beirn, Corporate Development Director at UDG, commented: “We are grateful to Pinsent Masons for their support on this strategic acquisition. Helen and her team have worked with us on a number of M&A transactions in the past including on the transformational disposal of our supply chain services business which completed earlier this year having received regulatory approvals. 

"They have built up a strong understanding of our business model and been with us over a number of years as our strategic direction has been to become a focused international healthcare services business. This understanding, together with their drive and focus to get deals done, and their expertise in the healthcare services sector, makes them trusted advisers.”   

Latest press releases

Show me all press releases

Pinsent Masons advises Chesnara on £260M acquisition of HSBC Life UK

Multinational law firm Pinsent Masons has advised listed European life and pensions consolidator Chesnara plc on its proposed £260 million acquisition of HSBC Life (UK) Limited from HSBC Bank plc.

Pinsent Masons advises on landmark Civil Works Alliance for Sizewell C

Multinational law firm Pinsent Masons has advised on the creation of a major delivery alliance for the Sizewell C nuclear power station in Suffolk, supporting the formation of a new alliance between Sizewell C and three leading construction firms.

Pinsent Masons has advised Tokai Carbon on the sale of its German subsidiary TOKAI ERFTCARBON GmbH

Multinational law firm Pinsent Masons has advised Tokai Carbon Co., Ltd. (“Tokai Carbon”) on the sale of its German subsidiary TOKAI ERFTCARBON GmbH (“TEG”), to Lenbach Equity Opportunities III. GmbH & Co. KG, which is exclusively advised by DUBAG Investment Advisory GmbH (“DUBAG”).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons promotes 24 to global partnership

Multinational law firm Pinsent Masons has today announced its latest round of partner promotions, with 24 set to join its global partnership on 1 May.

Pinsent Masons announces approval for opening of new office in China

Multinational law firm Pinsent Masons is continuing its expansion in Asia Pacific having received government approval to open our third office in mainland China.

Pinsent Masons advises on the insolvency proceedings of German aerospace start up Lilium

Multinational Pinsent Masons has advised the administrator of Lilium N.V. on the firm’s insolvency proceedings. Lilium N.V. is the holding company of Lilium GmbH and Lilium eAircraft GmbH. All three entities have been in German insolvency proceedings since October 2024.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.